CN106434443A - Production process of sodium hyaluronate - Google Patents

Production process of sodium hyaluronate Download PDF

Info

Publication number
CN106434443A
CN106434443A CN201610844974.7A CN201610844974A CN106434443A CN 106434443 A CN106434443 A CN 106434443A CN 201610844974 A CN201610844974 A CN 201610844974A CN 106434443 A CN106434443 A CN 106434443A
Authority
CN
China
Prior art keywords
fermentation
hyaluronate sodium
production technology
culture
ultrafiltration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610844974.7A
Other languages
Chinese (zh)
Other versions
CN106434443B (en
Inventor
巴奉良
惠贤秋
肖馗缨
马骞寰
牛玲晓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DONGYING FOSTER BIOLOGICAL ENGINEERING Co.,Ltd.
Original Assignee
DONGYING FUSITE BIO-ENGINEERING Co Ltd
CHINA EASTAR HOLDINGS GROUP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DONGYING FUSITE BIO-ENGINEERING Co Ltd, CHINA EASTAR HOLDINGS GROUP Co Ltd filed Critical DONGYING FUSITE BIO-ENGINEERING Co Ltd
Priority to CN201610844974.7A priority Critical patent/CN106434443B/en
Publication of CN106434443A publication Critical patent/CN106434443A/en
Application granted granted Critical
Publication of CN106434443B publication Critical patent/CN106434443B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a production process of sodium hyaluronate. A strain high in hyaluronic acid yield is screened out, improved fermentation technology is combined, production period is short, and the production process is simple; raw and auxiliary materials are common and easy to get, production is easy to control, impurity content is lower, the production process is suitable for industrial large-scale production requirements and high in yield, and production cost is lowered greatly.

Description

A kind of production technology of hyaluronate sodium
Technical field
The present invention relates to hyaluronic acid production technical field, more particularly to a kind of production technology of hyaluronate sodium.
Background technology
The technique fermentation period that Production by Microorganism Fermentation hyaluronic acid is adopted is long, and fermentation technology can not be according to strain properties Carry out, cause bacterial activity be excited, hyaluronic acid productivity is low, poor product quality.Contain thalline, protein in fermentation liquid And the material such as nucleic acid, extract extraction ratio that hyaluronic acid not only has high demands and its molecule does not occur depolymerization, and have high demands Product purity, and from fermentation liquid extract hyaluronic acid technical process can directly affect hyaluronic acid Yield and quality and Production cost.
The new fermentation strain of exploitation, meanwhile, improve fermentation technology and extraction process according to strain properties transparent to improve The quality and yield of matter acid sodium, is the technical problem to be solved in the invention.
Content of the invention
The purpose of the present invention is aiming at above-mentioned defect and provides a kind of production technology of hyaluronate sodium.This Bright filter out the high strain of hyaluronic acid productivity, in conjunction with improved fermentation technique, with short production cycle, simple production process, former auxiliary Material is common to be easy to get, and production is easily controllable, and impurity content is lower, and suitable industrialization large-scale production is required, high income, and significantly Reduce production cost.
A kind of production Technology scheme of hyaluronate sodium of the present invention is to comprise the following steps:
(1)Malian drainage(Streptococcus equi subsp. zooepidemicus)DCS005 shaking flask kind Sub- liquid culture;
(2)Strain expanded culture;
(3)Fermentation, is first passed through the fermentation of aseptic oxygen-containing air, then is passed through nitrogen continuation fermentation;
(4)Fermentation liquid is diluted with water to 6-8 times of fermentating liquid volume, addition kieselguhr and activated carbon in diluent, 40 DEG C Filter press after insulated and stirred, collects filtrate;Ultrafiltration is carried out to filtrate, removes the coloring matter of metal ion and small molecule;
(5)Solution after ultrafiltration is added the Sodium Chloride of 0.6mol/L, adds ethanol until completely dissolved, precipitate wine to terminal Precision number is 60%-65%, is sufficiently stirred for, staticly settles, and takes out precipitate hyaluronate sodium;By supernatant sucking filtration, Ran Houliu Plus the dehydrated alcohol of 0.3-2 times of volume, collected after centrifugation precipitation;
(6) washing dehydration dries:To be vacuum dried after hyaluronate sodium precipitates washed with EtOH, dehydration, obtain final product hyalomitome Sour sodium finished product.
Malian drainage used by the present invention(Streptococcus equi subsp. zooepidemicus) DCS005, the Malian drainage is in China Committee for Culture Collection of Microorganisms's common micro-organisms center guarantor at present Hide, address:Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, postcode:100101, its deposit number is:CGMCC No.12782, The Latin title of strain isStreptococcus equi subsp. zooepidemicus, join the microorganism of evidence(Strain): DCS005, preservation date is on July 14th, 2016.
Step(1)、(2)、(3)In culture fluid include starch 1% by weight percentage, sucrose 0.5%, Carnis Bovis seu Bubali cream 0.5%th, yeast powder 0.5%, dipotassium hydrogen phosphate 0.02%, sodium hydroxide 0.05%, balance of water, pH7.0-7.3.
Step(1)In, condition of culture is:38.5 DEG C culture 12-16 hour.
Step(2)In, it is 12-16 hour that condition of culture is 38.5 DEG C of temperature, pH7.0-7.3, incubation time, tank pressure 0.05MPa.
Step(3)Specifically, after being passed through aseptic oxygen-containing air 37-40 DEG C fermentation 18-32 hour, being passed through 39-45 DEG C of nitrogen Continue fermentation, be passed through the nitrogen stage be simultaneously introduced concentration for 800g/L glucose 300mL, fermentation liquid pH fall per minute Terminate fermentation during less than 0.01, fermentation broth viscosity is detected, fermentation liquid is pressed in settling tank, wherein, fermentation tank tank pressure 0.05MP.
Kieselguhr addition is the 2% of fermentating liquid volume, and activated carbon addition is the 2% of fermentating liquid volume.
Ultrafiltration retaining molecular weight used by ultrafiltration is 30,000-50,000, and ultrafiltration is carried out in below 0.5MPa.
Beneficial effects of the present invention are:
The present invention filters out the high strain of hyaluronic acid productivity, in conjunction with improved fermentation technique, with short production cycle, production technology letter Single, supplementary material is common to be easy to get, and production is easily controllable, and impurity content is lower, and suitable industrialization large-scale production is required, high income, And greatly reduce production cost.Highly purified hyaluronate sodium can be obtained inexpensive, hyaluronic acid and its purity salt are up to 99.6%, glucuronic acid purity is more than 45%, and loss of molecular weight rate is less than 11%, and protein content is less than 0.04%.
Specific embodiment:
For a better understanding of the present invention, technical scheme is described in detail with instantiation below, but the present invention It is not limited thereto.
Embodiment 1
Malian drainage used by the present invention(Streptococcus equi subsp. zooepidemicus) DCS005, the Malian drainage is in China Committee for Culture Collection of Microorganisms's common micro-organisms center guarantor at present Hide, address:Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, postcode:100101, its deposit number is:CGMCC No.12782, The Latin title of strain isStreptococcus equi subsp. zooepidemicus, join the microorganism of evidence(Strain): DCS005, preservation date is on July 14th, 2016.
A kind of production technology of hyaluronate sodium, comprises the following steps:
(1)Malian drainage(Streptococcus equi subsp. zooepidemicus)DCS005 shaking flask kind Sub- liquid culture, condition of culture is:38.5 DEG C culture 12-16 hour;
(2)Strain expanded culture, it is 12-16 hour that condition of culture is 38.5 DEG C of temperature, pH7.0-7.3, incubation time, tank pressure 0.05MPa;
(3)Fermentation, after being passed through aseptic oxygen-containing air 37-40 DEG C fermentation 18-32 hour, it is passed through 39-45 DEG C of nitrogen and continues fermentation, Being passed through the nitrogen stage is simultaneously introduced glucose 300mL, fermentation liquid pH per minute fall of the concentration for 800g/L less than 0.01 When terminate fermentation, detect fermentation broth viscosity, by fermentation liquid be pressed into settling tank in, wherein, fermentation tank tank pressure 0.05MP;
(4)Fermentation liquid is diluted with water to 6-8 times of fermentating liquid volume, and the kieselguhr of fermentating liquid volume 2% is added in diluent With the activated carbon of fermentating liquid volume 2%, filter press after 40 DEG C of insulated and stirred, filtrate is collected;In below 0.5MPa retention point Son amount carries out ultrafiltration for 30,000-50,000 ultrafilter membrane to filtrate, removes the coloring matter of metal ion and small molecule;
(5)Solution after ultrafiltration is added the Sodium Chloride of 0.6mol/L, adds ethanol until completely dissolved, precipitate wine to terminal Precision number is 60%-65%, is sufficiently stirred for, staticly settles, and takes out precipitate hyaluronate sodium;By supernatant sucking filtration, Ran Houliu Plus the dehydrated alcohol of 0.3-2 times of volume, collected after centrifugation precipitation;
(6) washing dehydration dries:To be vacuum dried after hyaluronate sodium precipitates washed with EtOH, dehydration, obtain final product hyalomitome Sour sodium finished product.
Step(1)、(2)、(3)In culture fluid include starch 1% by weight percentage, sucrose 0.5%, Carnis Bovis seu Bubali cream 0.5%th, yeast powder 0.5%, dipotassium hydrogen phosphate 0.02%, sodium hydroxide 0.05%, balance of water, pH7.0-7.3.
The present invention inexpensive can be obtained highly purified hyaluronate sodium, and hyaluronic acid and its purity salt are up to 99.6%, Fructus Vitis viniferae Alduronic acid purity is more than 45%, and loss of molecular weight rate is less than 11%, and protein content is less than 0.04%.

Claims (8)

1. a kind of production technology of hyaluronate sodium, it is characterised in that comprise the following steps:
(1)Malian drainage(Streptococcus equi subsp. zooepidemicus)DCS005 shaking flask kind Sub- liquid culture;
(2)Strain expanded culture;
(3)Fermentation, is first passed through the fermentation of aseptic oxygen-containing air, then is passed through nitrogen continuation fermentation;
(4)Fermentation liquid is diluted with water to 6-8 times of fermentating liquid volume, addition kieselguhr and activated carbon in diluent, 40 DEG C Filter press after insulated and stirred, collects filtrate;Ultrafiltration is carried out to filtrate;
(5)Solution after ultrafiltration is added the Sodium Chloride of 0.6mol/L, adds ethanol until completely dissolved, precipitate wine to terminal Precision number is 60%-65%, is sufficiently stirred for, staticly settles, and takes out precipitate hyaluronate sodium;By supernatant sucking filtration, Ran Houliu Plus the dehydrated alcohol of 0.3-2 times of volume, collected after centrifugation precipitation;
(6) washing dehydration dries:To be vacuum dried after hyaluronate sodium precipitates washed with EtOH, dehydration, obtain final product hyaluronic acid Sodium finished product.
2. a kind of production technology of hyaluronate sodium according to claim 1, it is characterised in that described streptococcus equi beast Epidemic disease subspecies(Streptococcus equi subsp. zooepidemicus)DCS005, which is in Chinese microorganism strain preservation Administration committee's common micro-organisms center preservation, its deposit number is:CGMCC No.12782, preservation date is in July, 2016 14 days.
3. a kind of production technology of hyaluronate sodium according to claim 1, it is characterised in that step(1)、(2)、(3) In culture fluid include starch 1% by weight percentage, sucrose 0.5%, Carnis Bovis seu Bubali cream 0.5%, yeast powder 0.5%, dipotassium hydrogen phosphate 0.02%th, sodium hydroxide 0.05%, balance of water, pH7.0-7.3.
4. a kind of production technology of hyaluronate sodium according to claim 1, it is characterised in that step(1)In, cultivate bar Part is:38.5 DEG C of culture 12-16 hours.
5. a kind of production technology of hyaluronate sodium according to claim 1, it is characterised in that step(2)In, cultivate bar Part is 38.5 DEG C of temperature, pH7.0-7.3, and incubation time is 12-16 hour, tank pressure 0.05MPa.
6. a kind of production technology of hyaluronate sodium according to claim 1, it is characterised in that step(3)Specifically, logical After entering aseptic oxygen-containing air 37-40 DEG C fermentation 18-32 hour, be passed through 39-45 DEG C of nitrogen and continue fermentation, be passed through the nitrogen stage while Terminate fermentation when adding concentration for glucose 300mL, the fermentation liquid pH fall per minute of 800g/L less than 0.01, detection is sent out Zymotic fluid viscosity, fermentation liquid is pressed in settling tank, wherein, fermentation tank tank pressure 0.05MP.
7. the production technology of a kind of hyaluronate sodium according to claim 1, it is characterised in that kieselguhr addition is for sending out The 2% of zymotic fluid volume, activated carbon addition is the 2% of fermentating liquid volume.
8. the production technology of a kind of hyaluronate sodium according to claim 1, it is characterised in that used by ultrafiltration, ultrafilter membrane cuts Stay molecular weight for 30,000-50,000, ultrafiltration is carried out in below 0.5MPa.
CN201610844974.7A 2016-09-23 2016-09-23 A kind of production technology of Sodium Hyaluronate Active CN106434443B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610844974.7A CN106434443B (en) 2016-09-23 2016-09-23 A kind of production technology of Sodium Hyaluronate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610844974.7A CN106434443B (en) 2016-09-23 2016-09-23 A kind of production technology of Sodium Hyaluronate

Publications (2)

Publication Number Publication Date
CN106434443A true CN106434443A (en) 2017-02-22
CN106434443B CN106434443B (en) 2018-05-15

Family

ID=58166986

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610844974.7A Active CN106434443B (en) 2016-09-23 2016-09-23 A kind of production technology of Sodium Hyaluronate

Country Status (1)

Country Link
CN (1) CN106434443B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109536550A (en) * 2018-12-06 2019-03-29 上海景峰制药有限公司 A kind of Sodium Hyaluronate and preparation method thereof
CN109913518A (en) * 2018-08-17 2019-06-21 上海昊海生物科技股份有限公司 A kind of pipeline preparation method of Sodium Hyaluronate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102435A (en) * 1994-08-17 1995-05-10 桂平县生物技术开发公司 Method for producing sodium hyaluronate by microbial fermentation
CN101643760A (en) * 2009-09-04 2010-02-10 四川理工学院 Method for increasing the yield of hyaluronic acid
CN103173507A (en) * 2011-12-23 2013-06-26 宁波林叶生物科技有限公司 Production technology for fermentatively producing sodium hyaluronate by utilizing bacterium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102435A (en) * 1994-08-17 1995-05-10 桂平县生物技术开发公司 Method for producing sodium hyaluronate by microbial fermentation
CN101643760A (en) * 2009-09-04 2010-02-10 四川理工学院 Method for increasing the yield of hyaluronic acid
CN103173507A (en) * 2011-12-23 2013-06-26 宁波林叶生物科技有限公司 Production technology for fermentatively producing sodium hyaluronate by utilizing bacterium

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109913518A (en) * 2018-08-17 2019-06-21 上海昊海生物科技股份有限公司 A kind of pipeline preparation method of Sodium Hyaluronate
CN109536550A (en) * 2018-12-06 2019-03-29 上海景峰制药有限公司 A kind of Sodium Hyaluronate and preparation method thereof

Also Published As

Publication number Publication date
CN106434443B (en) 2018-05-15

Similar Documents

Publication Publication Date Title
JPWO2007142285A1 (en) Purification method of hyaluronate
CN107151685B (en) Method for producing chondroitin sulfate by fermentation method
CN105418694A (en) Preparation method of trehalose
CN104059169B (en) A kind of hyaluronic purifying technique
CN113354877A (en) Epsilon-polylysine compound and preparation method and application thereof
CN102559799A (en) Preparation method for algae endophytic fungi exocellular polysaccharide
JP6592500B2 (en) Purification method of fidaxomycin
CN103695325B (en) A kind of candida tropicalis and a kind of microbial method prepare the method for Valine
CN106434443A (en) Production process of sodium hyaluronate
Lin et al. Screening and identification of a strain of Aureobasidium pullulans and its application in potato starch industrial waste
CN105695340A (en) Aspergillus oryzae and application thereof
CN109504725B (en) Method for preparing high-purity hericium erinaceus polysaccharide by fermenting hericium erinaceus and fermentation culture medium
CN108949713B (en) Preparation method of aspergillus oryzae fermentation broth and application of aspergillus oryzae fermentation broth in production of fructo-oligosaccharide
CN104059865B (en) A kind of streptococcus zooepidemicus and prepare the production technology of hyaluronic acid with it
CN102838624A (en) Method for purifying clavulanic acid from fermentation liquor
CN106434444B (en) A kind of Malian drainage and its production technology for preparing hyaluronic acid
JPS62186797A (en) Biosynthesis of novel heteropolysaccharides
CN111607622A (en) Process method for producing 3-hydroxy butanone by using wheat B starch
CN116333907A (en) Bacillus and method for preparing vitronectin by using same
CN111100823B (en) Polymyxin B sulfate production strain, preparation method and application of polymyxin B sulfate
CN109705174B (en) Method for extracting tobramycin
CN109811023B (en) Fermentation preparation method of A82846B
CN114672520A (en) Method for producing erythritol
CN108315375B (en) Production method of oxidized nicotinamide adenine dinucleotide phosphate
CN102234673B (en) Fermentation culture medium and fermentation method for producing pentostatin by fermentation of streptomyces antibioticus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20200826

Address after: 257000 No.75 Huaihe Road, Dongying Economic Development Zone, Shandong Province

Patentee after: DONGYING FOSTER BIOLOGICAL ENGINEERING Co.,Ltd.

Address before: 257000, Shandong, Dongying, Kenli Town, West Tuo (Yong Xin Road, No. 98)

Co-patentee before: DONGYING FOSTER BIOLOGICAL ENGINEERING Co.,Ltd.

Patentee before: CHINA EASTAR HOLDINGS GROUP Co.,Ltd.

TR01 Transfer of patent right